Cder benefit risk and quality assessment IDIQ

Ended Indefinite Delivery Contract Awarded

Contract number
HHSF223201710025I
Awardee
Awarding agency
Task orders
14 $3,779,024 obligated

Award facts

Opportunity
  • FDA17RFP1176768 Solicitation number
Combined order value
  • $3,779,024 Current, with exercised options
  • $4,062,282 Potential, with all options
Last date to order 100% complete
IDV ceiling 94% used
$4,000,000.00
Award type
Single award
Who can order
Only the awarding agency
NAICS code
541690 Other Scientific and Technical Consulting Services
PSC
B529 Special Studies/Analysis- Scientific Data
Set-aside
8(a) Sole Source
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Firm Fixed Price
Legislative mandates
  • Other statutory authority

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
Longitudinal analysis of adverse events to support benefit risk assessment 75F40118F01011 Food and Drug Administration $168,208
New inspection protocol project (nipp) 75F40118F01014 Food and Drug Administration $256,827
Patient level analysis of benefit and risk 75F40118F01012 Food and Drug Administration $270,618
Senior scientist support services 75F40118F01013 Food and Drug Administration $89,443
Population level retrospective analysis of benefits and risks 75F40118F01008 Food and Drug Administration $515,920
Assessing benefit risk management maturity at cder follow-on 75F40118F01009 Food and Drug Administration $168,208
Subject matter expert support services 75F40118F01010 Food and Drug Administration $167,535
Neuropsychologist support 75F40118F01007 Food and Drug Administration $96,117
Senior subject matter expert 75F40118F01006 Food and Drug Administration $524,378
Regulatory health project manager 75F40118F01005 Food and Drug Administration $372,663
Mid-level analyst support HHSF22301004T Food and Drug Administration $232,803
Population level retrospective analysis of benefits and risks: across cancers HHSF22301002T Food and Drug Administration $503,341
A patient level analysis of benefit and risk non-small cell lung cancer HHSF22301001T Food and Drug Administration $264,020
Supporting the assessment of benefit risk management maturity HHSF22301003T Food and Drug Administration $148,945
Show all 14

Quick answers

Who was awarded contract HHSF223201710025I?

HHSF223201710025I was awarded to Caitta Inc. by Food and Drug Administration (Department of Health and Human Services) on September 8, 2017.

How much is contract HHSF223201710025I worth?

Orders under HHSF223201710025I have obligated $3,779,024. Their combined potential value, with all options, is $4,062,282. HHSF223201710025I's own ceiling is $4,000,000.

How many orders have been placed under contract HHSF223201710025I?

14 orders have been placed under HHSF223201710025I, the latest on September 21, 2018.

Who can order from contract HHSF223201710025I?

HHSF223201710025I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract HHSF223201710025I competed?

The extent of competition for HHSF223201710025I was not available for competition. The government received 1 offer. It was set aside: 8(a) Sole Source.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login